Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Roche Media News
Get the latest updates from Roche Media News directly as they happen.
Follow now 317 followers
Latest posts
Last updated 2 days ago
New England Journal of Medicine publishes phase III data showing single-dose Xofluza significantly reduces influenza virus transmission
2 days ago
Detailed results from the CENTERSTONE trial show treatment with Xofluza reduced the...
[Ad hoc announcement pursuant to Art. 53 LR] Roche continues good momentum into 2025 with 6% (CER) sales growth in the first quarter
3 days ago
Group sales grew by 6%1 at constant exchange rates (CER; 7% in...
Roche receives CE Mark for its Chest Pain Triage algorithm to enhance detection of Acute Coronary Syndrome (ACS)
4 days ago
Roche, in collaboration with Universitätsklinikum Heidelberg, has developed a Chest Pain Triage...
Roche to invest USD 50 billion in pharmaceuticals and diagnostics in the United States over the next five years
5 days ago
USD 50 billion commitment includes new state-of-the art research and development (R&D)...
European Commission approves Roche’s Columvi as the first bispecific antibody for diffuse large B-cell lymphoma after initial therapy
13 days ago
Approval based on Phase III STARGLO study where Columvi in combination with...
Roche presents novel therapeutic and diagnostic advancements in Alzheimer’s at AD/PD 2025
24 days ago
New trontinemab data continue to support rapid and deep, dose-dependent reduction of...
Roche provides update on Phase III OCREVUS high dose study in people with relapsing multiple sclerosis
25 days ago
MUSETTE trial was designed to determine whether a higher dose of the...
Roche Annual General Meeting 2025
about 1 month ago
Shareholders approved all proposals of the Board of Directors Severin Schwan was...
Roche to share latest scientific advancements from its neuromuscular portfolio at Muscular Dystrophy Association (MDA) 2025 conference
about 1 month ago
New Evrysdi five-year data from the SUNFISH study showed continued stabilisation of...
Roche enters into an exclusive collaboration & licensing agreement with Zealand Pharma to co-develop and co-commercialise petrelintide as a potential foundational therapy for people with overweight and obesity
about 2 months ago
Agreement allows for a range of potentially best-in-class therapy options as monotherapy...
Roche announces launch of Roche Genentech Innovation Center Boston based at Harvard’s Enterprise Research Campus in Allston
about 2 months ago
The new center will be a hub for both Roche and Genentech...
FDA accepts supplemental Biologics License Application for Roche’s Gazyva/Gazyvaro for the treatment of lupus nephritis
about 2 months ago
Gazyva/Gazyvaro is the only anti-CD20 monoclonal antibody in a randomised phase III...